Janus Henderson Group’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-31,075
Closed -$149K 2454
2025
Q3
$149K Hold
31,075
﹤0.01% 2372
2025
Q2
$283K Hold
31,075
﹤0.01% 2190
2025
Q1
$266K Sell
31,075
-1,418,089
-98% -$15M ﹤0.01% 2255
2024
Q4
$18.9M Sell
1,449,164
-99,266
-6% -$1.32M 0.01% 586
2024
Q3
$24.3M Sell
1,548,430
-344,306
-18% -$5.22M 0.01% 535
2024
Q2
$25.6M Buy
1,892,736
+72,669
+4% +$1.49M 0.01% 519
2024
Q1
$50.4M Sell
1,820,067
-253,761
-12% -$5.64M 0.03% 393
2023
Q4
$40M Sell
2,073,828
-252,335
-11% -$4.57M 0.02% 418
2023
Q3
$37.6M Sell
2,326,163
-2,165
-0.1% -$38.4K 0.02% 420
2023
Q2
$44.3M Sell
2,328,328
-258,525
-10% -$4.61M 0.03% 409
2023
Q1
$37.6M Buy
2,586,853
+1,024,852
+66% +$18.4M 0.02% 440
2022
Q4
$30.5M Buy
1,562,001
+533,937
+52% +$10.4M 0.02% 478
2022
Q3
$24.8M Buy
1,028,064
+1,013,869
+7,142% +$31.2M 0.01% 634
2022
Q2
$446K Sell
14,195
-4
-0% -$145 ﹤0.01% 1834
2022
Q1
$625K Buy
14,199
+2
+0% +$86 ﹤0.01% 1757
2021
Q4
$618K Buy
14,197
+7,144
+101% +$280K ﹤0.01% 1765
2021
Q3
$221K Buy
+7,053
New +$278K ﹤0.01% 2028

Other funds holding ACH

Janus Henderson Group's ACH Position: Q4 2025 in Review

Janus Henderson Group sold out of Accendra Health (ACH) in Q4 2025, closing a stake of 31,075 shares — an estimated $149K sold.

Janus Henderson Group first reported a position in ACH in Q3 2021 and held it in 17 quarters. The position peaked at $50.4M in Q1 2024. 168 funds tracked by Wall St. Rank hold ACH as of Q4 2025.

  • Janus Henderson Group reported no remaining Accendra Health position as of Q4 2025 after selling out during the quarter.
  • Janus Henderson Group sold 31,075 Accendra Health shares in Q4 2025, an estimated $149K.
  • Janus Henderson Group first reported a position in Accendra Health in Q3 2021 and held it in 17 quarters.
  • Janus Henderson Group's Accendra Health position peaked at $50.4M in Q1 2024.
  • 168 funds tracked by Wall St. Rank held Accendra Health as of Q4 2025.

Based on Janus Henderson Group's 13F filing for Q4 2025, filed 17 Feb 2026.